Genetic Engineering in the Press by GEG

Despite Alzheimer’s being one of the obvious targets for a biotech fighting CNS disorders, Amylon chose Katwijk‘s disease – an inherited orphan disease that causes cerebral hemorrhages. De Vlaam explained that he was “born and bred in an orphan disorders company” so was motivated to fight the unmet need of a disorder that “[would] otherwise never [have] seen a glimmer of hope for a potential therapy because it is overshadowed by a disease like Alzheimer’s.”